← Back to Search

Cochlear Implant

Open-label for Unilateral Hearing Loss (SSD Trial)

N/A
Waitlist Available
Led By Robert Shannon, PhD
Research Sponsored by Robert Shannon
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-activation
Awards & highlights

SSD Trial Summary

The purpose of this investigation is to determine the safety and preliminary efficacy of implanting a cochlear implant (CI) in the profoundly deaf ear of an adult with one normal hearing (NH) ear (termed "single-sided deaf" person, or SSD). The potential subjects will have been deafened post-lingually, thus, at one point the now deafened ear did conduct sound from the periphery. The MED-EL CI system will be implanted in ten (10) SSD patients.The long-term goal of this research program is to determine whether the CI, in combination with the NH ear, may provide improved localization ability and better speech understanding in noise, relative to performance before cochlear implantation (i.e., with the NH ear alone). A secondary long-term goal is to determine whether CI stimulation may reduce tinnitus severity, compared to tinnitus experienced prior to cochlear implantation or when the CI is turned off, after implantation.

Eligible Conditions
  • Unilateral Hearing Loss

SSD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-activation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-activation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Hearing in Noise Test (signal-to-noise ratio)
Pure-tone threshold average (dB)
Secondary outcome measures
Adverse Events

SSD Trial Design

1Treatment groups
Experimental Treatment
Group I: Open-labelExperimental Treatment1 Intervention
Cochlear Implant

Find a Location

Who is running the clinical trial?

Robert ShannonLead Sponsor
Med-El CorporationIndustry Sponsor
23 Previous Clinical Trials
1,003 Total Patients Enrolled
University of California, Los AngelesOTHER
1,530 Previous Clinical Trials
10,278,192 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~1 spots leftby Apr 2025